The results of this study are consistent with those of clinical trials which illustrated that GLP-1 RAs are associated with reductions in A1c for patients with T2D [26–28], as well as for patients with T2D and moderate renal impairment [4]. Here, GLP1R is linked to type 2 diabetes mellitus.